Zai Lab (ZLAB) Debt Ratio (2016 - 2026)

Zai Lab's (ZLAB) quarterly Debt Ratio came in at 0.2 in Q1 2026, up 32.04% year-on-year from 0.15 in Q1 2025, and up 11.85% quarter-over-quarter from 0.17 in Q4 2025.

Zai Lab (ZLAB) Debt Ratio (2016 - 2026) Analysis & Trends

Zai Lab has disclosed Debt Ratio across 6 years of filings, most recently posting 0.2 for Q1 2026.

  • Debt Ratio for Q1 2026 came in at 0.2, up 32.04% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.2 (up 32.04% YoY), and the FY2025 annual result was 0.17, up 57.06% from the prior year.
  • Debt Ratio came in at 0.2 for Q1 2026 at Zai Lab, up from 0.17 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.2 in Q1 2026 to a low of 0.05 in Q1 2024.
  • The 3-year median for Debt Ratio is 0.15 (2025), against an average of 0.13.
  • Across the five-year window, Debt Ratio soared 202.61% in 2025 and jumped 32.04% in 2026, its largest moves.
  • Zai Lab's Debt Ratio stood at 0.11 in 2024, then jumped by 57.06% to 0.17 in 2025, then gained by 11.85% to 0.2 in 2026.
  • The last three Debt Ratio figures came in at 0.2 (Q1 2026), 0.17 (Q4 2025), and 0.18 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.18
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Zai Lab 20.15 Bn 20.05 Bn 61.30 Mn 0.20

Historic Data

Download Data
DateValue
Mar 31, 2026 0.20
Dec 31, 2025 0.17
Sep 30, 2025 0.18
Jun 30, 2025 0.15
Mar 31, 2025 0.15
Dec 31, 2024 0.11
Sep 30, 2024 0.11
Jun 30, 2024 0.07
Mar 31, 2024 0.05
Dec 31, 2019 0.02
Dec 31, 2018 0.01
Dec 31, 2016 0.04